Enrico Heffler
Overview
Explore the profile of Enrico Heffler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
250
Citations
3239
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Buta F, Paoletti G, Bragato M, Giovannini M, Canonica G, Heffler E
Curr Opin Allergy Clin Immunol
. 2024 Aug;
24(6):529-535.
PMID: 39212626
Purpose Of Review: The full understanding of the long-term effectiveness and safety of allergen immunotherapy (AIT) for allergic respiratory diseases cannot be achieved through randomized controlled trials (RCTs) alone. However,...
12.
Costanzo G, Caruso C, Paoletti G, Baglivo I, Colantuono S, Bagnasco D, et al.
J Pers Med
. 2024 Aug;
14(8).
PMID: 39202045
Randomized controlled trials have demonstrated responses to clinical parameters, but a significant proportion of allergy patients in real-life settings would have been excluded from such studies. Therefore, real-world research is...
13.
Guarnieri G, Olivieri B, Latorre M, Rizzi A, Blasi F, Canonica G, et al.
Eur Clin Respir J
. 2024 Aug;
11(1):2381307.
PMID: 39161972
Objective: Initiated by the Severe Asthma Network Italy (SANI), this study aims to explore asthma patients' perceptions of disease severity, differentiating between mild and severe asthma. The objective is to...
14.
Migliorisi G, Mastrorocco E, Dal Buono A, Gabbiadini R, Pellegatta G, Spaggiari P, et al.
J Clin Med
. 2024 Jul;
13(14).
PMID: 39064159
Background/objectives: Inflammatory bowel disease (IBD) and eosinophilic gastrointestinal diseases (EGIDs) are complex, multifactorial chronic inflammatory disorders affecting the gastrointestinal tract. Their epidemiology, particularly for eosinophilic esophagitis (EoE), is increasing worldwide,...
15.
Denton E, Hew M, Peters M, Upham J, Bulathsinhala L, Tran T, et al.
Allergy
. 2024 Jun;
79(10):2700-2716.
PMID: 38923444
Background: Biologic asthma therapies reduce exacerbations and long-term oral corticosteroids (LTOCS) use in randomized controlled trials (RCTs); however, there are limited data on outcomes among patients ineligible for RCTs. Hence,...
16.
Lugogo N, Heffler E, Plaza V, Hilberg O, Xia C, Nash S, et al.
J Asthma Allergy
. 2024 Jun;
17:551-556.
PMID: 38860029
No abstract available.
17.
Ghelli C, Costanzo G, Canonica G, Heffler E, Paoletti G
Curr Opin Allergy Clin Immunol
. 2024 May;
24(4):251-256.
PMID: 38814736
Purpose Of Review: To acknowledge, the newly available treatments for food allergy described in the latest scientific literature, such as oral immunotherapy (OIT), biologics and the combination of them in...
18.
Scelo G, Tran T, Le T, Fageras M, Dorscheid D, Busby J, et al.
J Allergy Clin Immunol Pract
. 2024 May;
12(9):2347-2361.
PMID: 38768896
Background: Biologic effectiveness is often assessed as response, a term that eludes consistent definition. Identifying those most likely to respond in real-life has proven challenging. Objective: To explore definitions of...
19.
Lamacchia D, Nappi E, Marzio V, Locatelli F, Messina M, Heffler E
Curr Opin Allergy Clin Immunol
. 2024 May;
24(4):257-265.
PMID: 38743499
Purpose Of Review: The aim of this review is to provide an account of the focus of therapeutic strategies for hereditary angioedema (HAE), give a brief overview of those used...
20.
Pelaia C, Zannoni E, Paoletti G, Marzio V, Heffler E, Carron-Herrero A
Curr Opin Allergy Clin Immunol
. 2024 May;
24(4):230-236.
PMID: 38713864
Purpose Of Review: The aim of this study was Describe the latest evidence related to the concept of clinical remission in patients with severe asthma, focusing on the lights and...